Liver Cancer Trial, Recruiting NCT06681818 Sponsor: Englewood Hospital and Medical Center Condition: Liver Cancer
Back to Liver Cancer

Liver Cancer Trial, Recruiting

NCT06681818
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are planning to have surgery to remove part of their liver, either due to a primary liver condition or cancer that has spread to the liver
  • People who are able to understand and are willing to sign a consent form agreeing to take part

Who may not be able to join:

  • People under 18 years of age
  • People who are considered part of a vulnerable population (such as those who may have difficulty making fully independent decisions), except for women of childbearing age who have a negative pregnancy test result

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 9 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cherif Boutros, MD, Englewood Hospital

Phone: 2018943418

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Englewood Hospital and Medical Center
Registry
ClinicalTrials.gov
Start date
21 November 2025
Est. completion
1 January 2039

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

correlation of carbon monoxide levels in exhaled breath with quantity and quality of liver regeneration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov